Relistor Solution For Injection 12Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Relistor: Solution for injection (12mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Relistor 12mg/0.6ml Soln Inj
Drug Image file default-drug-image.png
Relistor 12mg/0.6ml Soln Inj

What is this Medicine?

METHYLNALTREXONE (METH il nal TREX one) is used to treat constipation caused by opioids (pain medicine). Immediately tell your health care professional if you stop taking your opioid pain medicine.

CVS Pharmacy Patient Statistics for Relistor: Solution for injection(12mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Relistor 12mg/0.6ml Solution for Injection

NDC: 656490551
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Opiate Agonist-induced Constipation

Storage Information
Protect from light
Do not freeze
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Relistor 12mg/0.6ml Solution for Injection

Reported Side Effects for Relistor 12mg/0.6ml Solution for Injection

Loose Stools Incidence:
5.5%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
6.7%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
7.3%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
11.5%*
Severity: MILD
Onset: EARLY
Gas Incidence:
13.3%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
28.5%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Relistor

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.